Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer
Completed
Conditions studied: Ovarian Cancer, Malignant Tumor of Peritoneum, Quality of Life
In brief
RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of the treatment on these patients. PURPOSE: This clinical trial studies the effects of chemotherapy given by mouth versus chemotherapy given by infusion on quality of life in patients with recurrent ovarian epithelial cancer.
Key facts
- Study ID
- NCT00004909
- Run by
- Northwestern University
- People needed
- 40
- Starts
- 1999-11-01
- Expected to finish
- 2002-11-01
- Last updated by the study team
- 2011-02-21
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.